EXUDATIVE MACULOPATHY

Macular degeneration is a major cause of vision loss in people over 55.

The macula is the central part of the retina, where light comes into focus from the outside. It is responsible for the most important part of vision, the central one, which allows us to discriminate details such as people's faces and to read.

"Maculopathies" refers to a group of pathologies, with various characteristics and prognoses, affecting the macula. In exudative maculopathies , which are the most serious and rapidly progressive forms, the macula is damaged by the growth of small disorganized blood vessels that exude fluid and blood, irreparably damaging the retina and therefore central vision.

A characteristic symptom of active exudative maculopathy is distorted vision, together with visual loss or the vision of a fixed spot in the central part of the visual field.

The treatment of these exudative maculopathies is based first of all on the correct diagnosis and characterization through tests such as OCT , Angio-OCT and possibly Fluorangiography .

Once the type of maculopathy has been identified, treatment is performed through injections of drugs called "Anti-VEGF" which have the purpose of healing these small disorganized blood vessels and therefore stabilize the clinical picture as much as possible. The timeliness of treatment and the correct application of standardized treatment protocols are the most important weapons in the control of these serious pathologies.

The surgical interventions are performed at the headquarters of the Istituto Auxologico Italiano "Capitanio" in Via Mercalli 28 - 20122 Milan